Atyr Pharma Inc [ATYR] stock prices are up 8.39% to $2.97 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ATYR shares have gain 13.36% over the last week, with a monthly amount drifted -25.56%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Atyr Pharma Inc [NASDAQ: ATYR] stock has seen the most recent analyst activity on February 18, 2025, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $16. On October 04, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $17 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $9 on September 05, 2024. Oppenheimer downgraded its rating to a Perform. RBC Capital Mkts started tracking with a Outperform rating for this stock on October 12, 2021, and assigned it a price target of $22. In a note dated September 21, 2021, Piper Sandler initiated an Overweight rating and provided a target price of $19 on this stock.
The stock price of Atyr Pharma Inc [ATYR] has been fluctuating between $1.42 and $4.66 over the past year. Atyr Pharma Inc [NASDAQ: ATYR] shares were valued at $2.97 at the most recent close of the market.
Analyzing the ATYR fundamentals
Gross Profit Margin for this corporation currently stands at -3.91% with Operating Profit Margin at -289.0%, Pretax Profit Margin comes in at -272.43%, and Net Profit Margin reading is -272.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -0.85 and Total Capital is -0.83. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.77 points at the first support level, and at 2.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.15, and for the 2nd resistance point, it is at 3.32.
Ratios To Look Out For
It’s worth pointing out that Atyr Pharma Inc [NASDAQ:ATYR]’s Current Ratio is 5.48. As well, the Quick Ratio is 5.48, while the Cash Ratio is 0.74. Considering the valuation of this stock, the price to sales ratio is 1147.45, the price to book ratio is 3.56.
Transactions by insiders
Recent insider trading involved Gross Jane A, Director, that happened on Mar 17 ’25 when 3750.0 shares were purchased. Chief Financial Officer, Broadfoot Jill Marie completed a deal on Feb 04 ’25 to sell 1254.0 shares. Meanwhile, General Counsel DENYES NANCY sold 899.0 shares on Feb 04 ’25.
